Ligand profile
PFM
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_02854 — Putrescine aminotransferase
Identifiers
Database identifiers and provenance.
- Ligand ID
PFM- PDB
2oat- UniProt (similar protein)
P04181- Target protein
- KP13_02854
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 183.4
- −1 ≤ LogP ≤ 5 0.96
- MW ≤ 500 Da 374.3
- LogP ≤ 5 0.96
- H-bond donors ≤ 5 6
- H-bond acceptors ≤ 10 7
- Rotatable bonds ≤ 10 8
- TPSA ≤ 140 Ų 183.4
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cc1c(c(c(cn1)COP(=O)(O)O)\C=C\C(=C\C[C@@H](C(=O)O)N)\O)OCc1c(c(c(cn1)COP(=O)(O)O)\C=C\C(=C\C[C@@H](C(=O)O)N)\O)O
InChI=1S/C14H19N2O8P/c1-8-13(18)11(9(6-16-8)7-24-25(21,22)23)4-2-10(17)3-5-12(15)14(19)20/h2-4,6,12,17-18H,5,7,15H2,1H3,(H,19,20)(H2,21,22,23)/b4-2+,10-3-/t12-/m0/s1InChI=1S/C14H19N2O8P/c1-8-13(18)11(9(6-16-8)7-24-25(21,22)23)4-2-10(17)3-5-12(15)14(19)20/h2-4,6,12,17-18H,5,7,15H2,1H3,(H,19,20)(H2,21,22,23)/b4-2+,10-3-/t12-/m0/s1
FKVMVCAAQIJMAO-UGEYCXAUSA-NFKVMVCAAQIJMAO-UGEYCXAUSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF00202
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand PFM →
- PDB RCSB structure 2oat →
- UniProt UniProt P04181 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “PFM”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_02854.
PDB 12
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 4
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).